| Year |
Citation |
Score |
| 2018 |
Garibotto V, Wissmeyer M, Giavri Z, Goldstein R, Seimbille Y, Seeck M, Ratib O, Haller S, Picard F. Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30269157 DOI: 10.1007/S00259-018-4175-0 |
0.326 |
|
| 2017 |
Colin DJ, Inkster JAH, Germain S, Seimbille Y. Preclinical validations of [F]FPyPEGCBT-(RGDfK): aF-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis. Ejnmmi Radiopharmacy and Chemistry. 1: 16. PMID 29564392 DOI: 10.1186/S41181-016-0019-Z |
0.393 |
|
| 2017 |
Lamanna G, Tabouret-Viaud C, Rager O, Jorcano S, Vees HJ, Seimbille Y, Zaidi H, Ratib O, Buchegger F, Miralbell R, Zilli T, Garibotto V. Long-term Results of a Comparative PET/CT and PET/MRI Study of 11 C-Acetate and 18 F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer. Clinical Nuclear Medicine. PMID 28240662 DOI: 10.1097/Rlu.0000000000001609 |
0.363 |
|
| 2016 |
Radchenko V, Engle JW, Roy C, Griswold J, Nortier MF, Birnbaum ER, Brugh M, Mirzadeh S, John KD, Fassbender ME, Zhai C, Franssen GM, Petrik M, Laverman P, Decristoforo C, ... ... Seimbille Y, et al. 18th European Symposium on Radiopharmacy and Radiopharmaceuticals Ejnmmi Radiopharmacy and Chemistry. 1: 10. DOI: 10.1186/S41181-016-0012-6 |
0.557 |
|
| 2015 |
Inkster JA, Colin DJ, Seimbille Y. A novel 2-cyanobenzothiazole-based (18)F prosthetic group for conjugation to 1,2-aminothiol-bearing targeting vectors. Organic & Biomolecular Chemistry. 13: 3667-76. PMID 25678209 DOI: 10.1039/C4Ob02637C |
0.39 |
|
| 2014 |
Monaco A, Michelin O, Prior J, Rüegg C, Scapozza L, Seimbille Y. Synthesis of a non-peptidic PET tracer designed for α5β1 integrin receptor. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 365-70. PMID 24634266 DOI: 10.1002/Jlcr.3190 |
0.396 |
|
| 2014 |
Buchegger F, Garibotto V, Zilli T, Allainmat L, Jorcano S, Vees H, Rager O, Steiner C, Zaidi H, Seimbille Y, Ratib O, Miralbell R. First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 41: 68-78. PMID 24104592 DOI: 10.1007/S00259-013-2540-6 |
0.359 |
|
| 2013 |
Monaco A, Zoete V, Alghisi GC, Rüegg C, Michelin O, Prior J, Scapozza L, Seimbille Y. Synthesis and in vitro evaluation of a novel radioligand for αvβ3 integrin receptor imaging: [18F]FPPA-c(RGDfK). Bioorganic & Medicinal Chemistry Letters. 23: 6068-72. PMID 24095096 DOI: 10.1016/J.Bmcl.2013.09.031 |
0.398 |
|
| 2012 |
Miralbell R, Vees H, Ratib O, Wissmeyer M, Steiner C, Seimbille Y, Khan HG, Buchegger F. Long-Term Post-Treatment MR and PET/CT Imaging in Prostate Cancer Patients in Complete Remission after Curative Radiotherapy with or without Androgen Deprivation: The Image of Cure Journal of Nuclear Medicine and Radiation Therapy. 2011. DOI: 10.4172/2155-9619.1000118 |
0.353 |
|
| 2008 |
Su H, Seimbille Y, Ferl GZ, Bodenstein C, Fueger B, Kim KJ, Hsu YT, Dubinett SM, Phelps ME, Czernin J, Weber WA. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1089-99. PMID 18239919 DOI: 10.1007/S00259-007-0636-6 |
0.319 |
|
| 2006 |
Azarian V, Gangloff A, Seimbille Y, Delaloye S, Czernin J, Phelps ME, Silverman DHS. Synthesis and liposome encapsulation of a novel 18F-conjugate of ω-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography Journal of Labelled Compounds and Radiopharmaceuticals. 49: 269-283. DOI: 10.1002/Jlcr.1029 |
0.347 |
|
| 2005 |
Seimbille Y, Phelps ME, Czernin J, Silverman DHS. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: Synthesis of18F-Iressa and related molecular probes Journal of Labelled Compounds and Radiopharmaceuticals. 48: 829-843. DOI: 10.1002/Jlcr.998 |
0.358 |
|
| 2005 |
Seimbille Y, Czernin J, Phelps ME, Silverman DHS. Synthesis of an18F-fluorobenzoate idarubicin derivative as new potential PET radiotracer to predict chemotherapy resistance Journal of Labelled Compounds and Radiopharmaceuticals. 48: 819-827. DOI: 10.1002/Jlcr.990 |
0.381 |
|
| 2004 |
Seimbille Y, Bénard F, Rousseau J, Pepin E, Aliaga A, Tessier G, van Lier JE. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780). Nuclear Medicine and Biology. 31: 691-8. PMID 15246359 DOI: 10.1016/J.Nucmedbio.2004.02.010 |
0.556 |
|
| 2002 |
Seimbille Y, Rousseau J, Bénard F, Morin C, Ali H, Avvakumov G, Hammond GL, van Lier JE. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals. Steroids. 67: 765-75. PMID 12123788 DOI: 10.1016/S0039-128X(02)00025-9 |
0.551 |
|
| 2002 |
Seimbille Y, Bénard F, Lier JEv. Synthesis of 16α-fluoro ICI 182,780 derivatives: powerful antiestrogens to image estrogen receptor densities in breast cancer by positron emission tomography Journal of the Chemical Society-Perkin Transactions 1. 2275-2281. DOI: 10.1039/B205571F |
0.321 |
|
| 2002 |
Seimbille Y, Ali H, Lier JEv. Synthesis of 2,16α- and 4,16α-difluoroestradiols and their 11β-methoxy derivatives as potential estrogen receptor-binding radiopharmaceuticals Journal of the Chemical Society-Perkin Transactions 1. 657-663. DOI: 10.1039/B110021C |
0.32 |
|
| 2001 |
Seimbille Y, Rousseau J, Bénard F, Ali H, Lier JEV. Synthesis of 2, 16α- and 4, 16α-[16α-18F]difluoroestradiols and their 11β-methoxy derivatives for estrogen receptor imaging Journal of Labelled Compounds and Radiopharmaceuticals. 44. DOI: 10.1002/Jlcr.25804401122 |
0.318 |
|
| Show low-probability matches. |